Workshops
IPVC 2024 workshops will focus on this year’s theme, “Equitable, Evidence-Based Approaches to HPV Disease”, the meeting promises to be a platform for the reporting of cutting-edge, international, HPV and animal papillomavirus research. Workshops organized by leading scientists and key opinion leaders in their fields will provide an opportunity for delegates to hear “state-of-the-art” developments in basic science, public health, and clinical science.
Workshops will be run by and have speakers who are worldwide leaders in the field. They will provide a unique forum for education and discussion.
Although workshops stand alone as an educational and scientific activity, they are designed to provide the necessary scientific background to follow the main Conference, where the latest knowledge in research will be presented. For junior scientists, the workshops will help them to be educated on both the basics and cutting-edge knowledge of papillomavirus biology, epidemiology, and prevention and control of papillomavirus infections and diseases.
A dedicated early careers track will also provide the opportunity for young scientists to showcase their work and make connections. The workshops will provide an overview to non-experts on all papillomavirus (PV)-related topics, from basic science to global health impact.
IPVC 2024 workshops will be a unique way to connect across the fields, and attendees will enjoy PV research from different perspectives and participate in wider scientific discussions.
Tuesday, November 12, 2024
Click on the sections below to learn more about the workshops. Please note the information might be subject to change.
INTERDISCIPLINARY WORKSHOPS
08:00 – 09:30 GMT
Interdisciplinary Workshop: Epidemiology and Basic Science of HPV Infection and Related Diseases
Chair: Suzanne Garland (Australia)
Chair: Kate Cuschieri (UK)
Chair: Sheila Graham (UK)
Welcome remarks from Co-Chairs
Suzanne Garland, Kate Cuschieri & Sheila Graham
Global burden of HPV-related cancers and diseases.
Laia Bruni (Spain)
Basics of HPV genomics and immune response to HPV.
Koenraad M Van Doorslaer (USA)
Overview of vaccine efficacy against multiple endpoints.
Deborah Jones-Watson (South Africa)
Overview of different approaches to cervical cancer screening in high, middle and low resource setting.
Chemtai Mungo (USA)
Discussion Panel led by co-chairs.
BASIC SCIENCE TRACK
10:00 – 11:30 GMT
Basic Science Workshop 1: New insights into the HPV life cycle
Chair: Alison McBride (USA)
Chair: Nagayasu Egawa (UK)
Chairs’ introduction
New insights into entry
Mario Schelhaas (Germany)
Signaling in the lifecycle
Andrew Macdonald (UK)
Replication
Frank Stubenrauch (Germany)
Late phases of the life cycle
Sheila Graham (UK)
Discussion
13:10 – 14:40 GMT
Basic Science Workshop 2: Host response to infection
Chair: Cary Moody (USA)
Chair: Merilyn Hibma (New Zealand)
Chair Introduction
Early stages of immune response and host interactions in response to infection
Dohun Pyeon (USA)
Viral gene expression at different sites of infection
John Doorbar (UK)
The DNA damage response in HPV infection
Cary Moody (USA)
The epithelial immune response to virus infection
Merilyn Hibma (New Zealand)
14:45 – 15:45 GMT
Basic Science Workshop 3: New Technologies in the study of HPV biology and disease
Chair:Katerina Strati (Greece)
Chair Introduction
Single cell genomic approaches in HPV research
Susanne Wells (USA)
Mouse models for papillomavirus infection and carcinogenesis
Megan Spurgeon (USA)
Organoids for studying HPV-driven cancers.
Cindrilla Chumduri (Denmark)
Discussion
CLINICAL SCIENCE TRACK
10:00 – 11:30 GMT
Clinical Science Workshop 1: The 3 pillars of cervical cancer elimination: HPV vaccination, screening and treatment
Chair: Sarah Feldman (USA)
Chair: Rebecca Luckett (USA)
HPV Vaccination: can we reach WHO targets for vaccination: Current challenges: Single dose vaccination- will it protect your patient and help expand coverage globally?
Nelly Mugo (Kenya)
Transitioning to Molecular Based testing: where and how, including self-screening
Nico Wentzensen (USA)
Management of HSIL in the HPV era
Maggie Cruikshank (UK)
Cervical Cancer eradication is possible: Debate *Interactive voting session.
Moderator: Sarah Feldman (USA)
Mark Einstein (USA): PRO
Sylvia De Sanjose (Spain): CON
13:10 – 14:40 GMT
Clinical Science Workshop 2: HPV: Updates
Chair: Barabara Moscicki (USA)
Chair: Omenge Orang’o (Kenya)
Latency Is this a new infection or an old one? Does it matter?
Patti Gravitt (USA)
Screening for Anal Cancer
Andreia Alburquerque (Portugal)
Oral pharyngeal Screening
Gypsyamber D’Souza (USA)
Screening for HPV related cancers in women with HIV
Beth Stier (USA)
Medical Treatments for dysplasia-of the cervix, vagina, vulva and anus
Sarah Feldman (USA)
Discussion
14:45 – 15:45 GMT
Clinical Science Workshop 3: Caring for the Patient
Chair: Maggie Cruikshank (UK)
Chair: Ida Ismail Pratt (UK)
Update on over the counter supplements-do they work?
Kimon Chatzitamatiou (Greece)
Patient Navigation: What is it, how can it help bring patients in for care.
Nancy Pena (USA)
Caring for the LGBTQ population
Cristyn Davies (Australia)
Discussion
PUBLIC HEALTH, EPIDEMIOLOGY AND IMPLEMENTATION SCIENCE TRACK
10:00 – 11:30 GMT
Public Health Workshop 1: HPV natural history and related diseases
Chair: Anna Giuliano (USA)
Chair: Ana Cecilia Rodriguez (Costa Rica)
Chair introduction to PH Workshop
HPV natural history in women
Barbara Moscicki (USA)
HPV natural history in men
Richard Gilson (UK)
RRP and HPV natural history in early childhood
Shazia Peer (South Africa)
Changing HPV epidemiology – prevention and early detection of HPV-related head and neck cancer
Tim Waterboer (Germany)
Panel Discussion with Q&A
13:10 – 14:40 GMT
Public Health Workshop 2: Prevention of HPV-related diseases
Chair: Talía Malagón (Canada)
Chair: Chemtai Mungo (USA)
Deep dive vaccine effectiveness, and duration of protection in women and men across multiple anatomic sites
Joakim Dillner (Sweden)
Global HPV vaccine uptake – countries with national programs, n and % females, males vaccinated by country income level, age group, etc.
Paul Bloem (Switzerland)
Cost-effectiveness/Modelling:vaccination and screening strategies
Kate Simms (Australia)
Alternative dose/1 dose HPV vaccination strategies
Susanne Kjaer (Denmark)
Vaccine hesitancy, how to build vaccine confidence
Yvonne Morrissey (Ireland)
Panel Discussion with Q&A
14:45 – 15:45 GMT
Public Health Workshop 3: The Path to Cervical Cancer Elimination
Chair: Yin Ling Woo (Malaysia)
Chair: Sharon Hanley (UK)
Introduction by Chairs
Vaccine implementation issues. Methods to overcome barriers.
Cathy Ndiaye (Senegal)
Cervical cancer screening implementation issues. Methods to overcome barriers, including self-sampling, etc.
Jeniffer Smith (USA)
Screen and Treat and HPV Testing: New Horizons
Andrew Valley (Australia)
Panel Discussion with Q&A
Please note that the workshops for IPVC 2024 are included in the conference fee. No additional fee or pre-registration is required.